Iqvia (IQV) Issues Q1 Earnings Guidance

Iqvia (NYSE:IQV) updated its first quarter earnings guidance on Wednesday. The company provided EPS guidance of $1.23-1.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.20. Iqvia also updated its FY18 guidance to $5.35-5.60 EPS.

Several research firms have commented on IQV. Mizuho lowered shares of Iqvia from a buy rating to a neutral rating and set a $90.00 price target on the stock. in a report on Thursday, November 9th. SunTrust Banks reaffirmed a hold rating and issued a $114.00 price target on shares of Iqvia in a report on Friday, November 3rd. Zacks Investment Research lowered shares of Iqvia from a buy rating to a hold rating in a report on Friday, January 19th. KeyCorp reaffirmed a sector weight rating and issued a $100.00 price target on shares of Iqvia in a report on Friday, November 10th. Finally, Morgan Stanley upped their price target on shares of Iqvia from $96.00 to $121.00 and gave the company an overweight rating in a report on Thursday, November 9th. Seven investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of Buy and a consensus price target of $109.71.

Iqvia (NYSE:IQV) opened at $100.06 on Wednesday. The firm has a market cap of $20,513.85, a PE ratio of 22.52, a price-to-earnings-growth ratio of 1.34 and a beta of 0.61. Iqvia has a 1 year low of $75.94 and a 1 year high of $110.67. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.22 and a quick ratio of 1.22.

In other Iqvia news, Director John Connaughton sold 1,163,191 shares of the company’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $102.00, for a total value of $118,645,482.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of the company’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $102.00, for a total transaction of $764,776,314.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,727,078 shares of company stock valued at $890,124,079. Insiders own 6.40% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was first published by American Banking News and is the property of of American Banking News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/02/14/iqvia-iqv-issues-q1-earnings-guidance.html.

Iqvia Company Profile

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply